Ditchcarbon
  • Contact
  1. Organizations
  2. Onyx Biotec Limited
Public Profile
Pharmaceutical Preparation Manufacturing
IN
updated 2 months ago

Onyx Biotec Limited Sustainability Profile

Company website

Onyx Biotec Limited, a prominent player in the biotechnology sector, is headquartered in India and operates extensively across various regions. Founded in 2010, the company has established itself as a leader in developing innovative biopharmaceuticals and advanced therapeutic solutions. Specialising in cutting-edge drug delivery systems and bioprocessing technologies, Onyx Biotec's core offerings are distinguished by their commitment to enhancing patient outcomes and streamlining production processes. The company has achieved significant milestones, including collaborations with leading research institutions and successful product launches that underscore its market position. With a focus on quality and innovation, Onyx Biotec Limited continues to drive advancements in the biotechnology industry, making a notable impact on healthcare solutions both locally and globally.

DitchCarbon Score

How does Onyx Biotec Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

14

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Onyx Biotec Limited's score of 14 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.

9%

Let us know if this data was useful to you

Onyx Biotec Limited's reported carbon emissions

Onyx Biotec Limited, headquartered in India, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that Onyx Biotec Limited may still be in the early stages of developing a comprehensive climate strategy. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate their carbon footprints. However, without specific commitments or data, it is challenging to assess Onyx Biotec Limited's position relative to its peers in terms of climate action and emissions management.

How Carbon Intensive is Onyx Biotec Limited's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Onyx Biotec Limited's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Onyx Biotec Limited's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Onyx Biotec Limited is in IN, which has a very high grid carbon intensity relative to other regions.

Onyx Biotec Limited's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Onyx Biotec Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Onyx Biotec Limited's Emissions with Industry Peers

Suven Pharmaceuticals Limited

IN
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Biogen

US
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251118.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy